H.C. Wainwright analyst Andres Maldonado initiated coverage of Erasca with a Buy rating and $10 price target. The analyst views Erasca’s pipeline as being the “best-in-class comprehensive attack” on the MAPK pathways, potentially yielding access to a $20B potential market in multiple indications by 2034.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ERAS: